AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Geneglim M 1mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Genezen Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Geneglim M 1mg/500mg Tablet ER

Diabex Duo 1mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can elevate glucose levels, increasing the risk of complications like kidney impairment, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan incorporating a balanced diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect of Diabex Duo. Learn to identify symptoms like tremors, sweating, dizziness, and headaches, and know how to respond appropriately. Regular meals and readily available fast-acting glucose sources, such as juice or candy, are essential preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other potential side effects include gastrointestinal upset (nausea, diarrhea, abdominal pain), altered taste perception, headaches, and upper respiratory infections. Weight gain is also a possibility. This medication is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before commencing treatment. Pregnant or lactating women should seek medical advice before use. Regular blood glucose monitoring is necessary, and your doctor may recommend blood tests to assess blood cell counts and liver function.

Primary Ingredients of Geneglim M 1mg/500mg Tablet ER

The provided text is "undefined". Therefore, no rephrasing is possible.

Uses of Geneglim M 1mg/500mg Tablet ER

Managing Type 2 Diabetes

Major Benefits of Geneglim M 1mg/500mg Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume Geneglim M 1mg/500mg Extended-Release Tablet with food.

Common Side effects of Geneglim M 1mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Geneglim M 1mg/500mg Tablet ER:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Geneglim M 1mg/500mg Extended-Release Tablet with food.

How Geneglim M 1mg/500mg Tablet ER works:

Geneglim M 1mg/500mg Extended-Release tablets combine glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol ingestion and Geneglim M 1mg/500mg Tablet ER is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Geneglim M 1mg/500mg tablets may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Geneglim M 1mg/500mg tablets are contraindicated for breastfeeding mothers due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Geneglim M 1mg/500mg Extended-Release tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Geneglim M 1mg/500mg Extended-Release tablets are contraindicated in patients exhibiting severe kidney disease. Close monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Geneglim M 1mg/500mg Extended-Release tablets cautiously. Dosage modification may be necessary. Physician consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Geneglim M 1mg/500mg Tablet ER :

For a missed Geneglim M 1mg/500mg Extended-Release tablet, take it immediately if you remember. Otherwise, omit the missed dose if your next scheduled intake is imminent and resume your normal dosing regimen. Avoid taking a double dose.

Facts to Know About Geneglim M 1mg/500mg Tablet ER

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Geneglim M 1mg/500mg Tablet ER

Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
Geneglim M 1mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Geneglim M 1mg/500mg Tablet ER and seek immediate medical attention.
Geneglim M 1mg/500mg Extended-Release Tablets combine glimepiride and metformin to manage type 2 diabetes. This medication improves blood sugar control in adults, complementing a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Geneglim M 1mg/500mg Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Geneglim M 1mg/500mg Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended annually by some researchers.
Geneglim M 1mg/500mg Tablet ER can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Geneglim M 1mg/500mg ER tablets with alcohol is unsafe. Alcohol can exacerbate the drug's blood sugar-lowering effect, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Geneglim M 1mg/500mg Tabl...
37
MRP 45
16% off